Abstract |
Cultured human epithelial cells infected with an ICP27 deletion strain of herpes simplex virus type 1 (HSV-1) show characteristic features of apoptotic cells including cell shrinkage, nuclear condensation, and DNA fragmentation. These cells do not show such apoptotic features when infected with a wild-type virus unless the infections are performed in the presence of a protein synthesis inhibitor. Thus, both types of virus induce apoptosis, but the ICP27-null virus is unable to prevent this process from killing the cells. In this report, we show that this ICP27-deficient virus induced apoptosis in human HEp-2 cells through a pathway which involved the activation of caspase-3 and the processing of the death substrates DNA fragmentation factor and poly(ADP-ribose) polymerase. The induction of apoptosis by wild-type HSV-1 occurred prior to 6 h postinfection (hpi), and de novo viral protein synthesis was not required to induce the process. The ability of the virus to inhibit apoptosis was shown to be effective between 3 to 6 hpi. Wild-type HSV-1 infection was also able to block the apoptosis induced in cells by the addition of cycloheximide, staurosporine, and sorbitol. While U(S)3- and ICP22-deficient viruses showed a partial prevention of apoptosis, deletion of either the U(L)13 or vhs gene products did not affect the ability of HSV-1 to prevent apoptosis in infected cells. Finally, we demonstrate that in UV-inactivated viruses, viral binding and entry were not sufficient to induce apoptosis. Taken together, these results suggest that either gene expression or another RNA metabolic event likely plays a role in the induction of apoptosis in HSV-1-infected human cells.
|
Authors | M Aubert, J O'Toole, J A Blaho |
Journal | Journal of virology
(J Virol)
Vol. 73
Issue 12
Pg. 10359-70
(Dec 1999)
ISSN: 0022-538X [Print] United States |
PMID | 10559354
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Caspase Inhibitors
- Enzyme Inhibitors
- ICP22 protein, human herpesvirus 1
- ICP27 protein, human herpesvirus 1
- Immediate-Early Proteins
- Viral Proteins
- Viral Regulatory and Accessory Proteins
- herpes simplex virus, type 1 protein ICP4
- virion host shutoff protein, Simplexvirus
- EUS1 protein, Equine herpesvirus 1
- Sorbitol
- Protein Kinases
- UL13 protein, Simplexvirus
- Protein Serine-Threonine Kinases
- US3 protein, Human herpesvirus 1
- Ribonucleases
- CASP3 protein, human
- Caspase 3
- Staurosporine
|
Topics |
- Animals
- Apoptosis
- Caspase 3
- Caspase Inhibitors
- Chlorocebus aethiops
- Enzyme Inhibitors
(pharmacology)
- Gene Deletion
- Herpesvirus 1, Human
(metabolism, physiology)
- Humans
- Immediate-Early Proteins
(biosynthesis, genetics, physiology)
- Protein Kinases
(genetics)
- Protein Serine-Threonine Kinases
(genetics)
- Ribonucleases
- Sorbitol
- Staurosporine
(pharmacology)
- Time Factors
- Tumor Cells, Cultured
- Vero Cells
- Viral Proteins
(genetics)
- Viral Regulatory and Accessory Proteins
|